A Hong Kong biotechnology start-up claims to have come up with a new procedure that could dramatically improve the efficiency and lower the cost of cancer screening.Phase Scientific International’s has developed a new way of preparing samples for liquid biopsy, a diagnostic screening tool to detect cancer cells or their DNA fragments in fluids such as blood and urine.In the short to medium term, the nascent technique of liquid biopsy could allow doctors to more accurately monitor a tumour’s…
↧